191 related articles for article (PubMed ID: 16815733)
1. Predictive value of in vitro safety studies.
Suter W
Curr Opin Chem Biol; 2006 Aug; 10(4):362-6. PubMed ID: 16815733
[TBL] [Abstract][Full Text] [Related]
2. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
Whitebread S; Hamon J; Bojanic D; Urban L
Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
[TBL] [Abstract][Full Text] [Related]
3. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
4. How omics technologies can contribute to the '3R' principles by introducing new strategies in animal testing.
Kroeger M
Trends Biotechnol; 2006 Aug; 24(8):343-6. PubMed ID: 16782220
[TBL] [Abstract][Full Text] [Related]
5. A search to predict potential for drug-induced cardiovascular toxicity.
Hamlin RL
Toxicol Pathol; 2006; 34(1):75-80. PubMed ID: 16507547
[TBL] [Abstract][Full Text] [Related]
6. New cell models and assays in cardiac safety profiling.
Meyer T; Sartipy P; Blind F; Leisgen C; Guenther E
Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):507-17. PubMed ID: 17696802
[TBL] [Abstract][Full Text] [Related]
7. Safety evaluation to support First-In-Man investigations I: kinetic and safety pharmacology studies.
Baldrick P
Regul Toxicol Pharmacol; 2008 Jul; 51(2):230-6. PubMed ID: 18501489
[TBL] [Abstract][Full Text] [Related]
8. Use and application of stem cells in toxicology.
Davila JC; Cezar GG; Thiede M; Strom S; Miki T; Trosko J
Toxicol Sci; 2004 Jun; 79(2):214-23. PubMed ID: 15014205
[TBL] [Abstract][Full Text] [Related]
9. An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs.
Jacobs A
Toxicol Lett; 2009 Apr; 186(1):32-5. PubMed ID: 18809476
[TBL] [Abstract][Full Text] [Related]
10. Computational toxicology--a tool for early safety evaluation.
Merlot C
Drug Discov Today; 2010 Jan; 15(1-2):16-22. PubMed ID: 19835978
[TBL] [Abstract][Full Text] [Related]
11. Safety evaluation to support First-In-Man investigations II: toxicology studies.
Baldrick P
Regul Toxicol Pharmacol; 2008 Jul; 51(2):237-43. PubMed ID: 18501490
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Torsades-de-Pointes screens: advantages and limitations of surrogate and direct approaches in evaluating proarrhythmic risk.
Gintant GA
Pharmacol Ther; 2008 Aug; 119(2):199-209. PubMed ID: 18621077
[TBL] [Abstract][Full Text] [Related]
13. Serum chemical biomarkers of cardiac injury for nonclinical safety testing.
Walker DB
Toxicol Pathol; 2006; 34(1):94-104. PubMed ID: 16507550
[TBL] [Abstract][Full Text] [Related]
14. Application of emerging technologies in toxicology and safety assessment: regulatory perspectives.
Leighton JK
Int J Toxicol; 2005; 24(3):153-5. PubMed ID: 16040567
[TBL] [Abstract][Full Text] [Related]
15. Preclinical testing on insects predicts human haematotoxic potentials.
Berger J
Lab Anim; 2009 Oct; 43(4):328-32. PubMed ID: 19505933
[TBL] [Abstract][Full Text] [Related]
16. What have we learned from pre-clinical juvenile toxicity studies?
Bailey GP; Mariën D
Reprod Toxicol; 2009 Sep; 28(2):226-9. PubMed ID: 19446432
[TBL] [Abstract][Full Text] [Related]
17. Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies.
Benbow JW; Aubrecht J; Banker MJ; Nettleton D; Aleo MD
Toxicol Lett; 2010 Sep; 197(3):175-82. PubMed ID: 20576494
[TBL] [Abstract][Full Text] [Related]
18. Preclinical assessment of cardiac toxicity.
Kettenhofen R; Bohlen H
Drug Discov Today; 2008 Aug; 13(15-16):702-7. PubMed ID: 18602016
[TBL] [Abstract][Full Text] [Related]
19. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
Lynch AM; Wilcox P
Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
[TBL] [Abstract][Full Text] [Related]
20. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
